(CercleFinance.com) - Danone announces that the acquisition of The Akkermansia Company (TAC), a Belgian biotics company, marks a strategic step forward in the field of gut health.
TAC has nearly 20 years of scientific expertise and has developed the Akkermansia muciniphila MucT strain, clinically proven to strengthen the intestinal barrier, reduce inflammation and combat metabolic disorders such as obesity, diabetes and cardiovascular disease.
This operation is in line with Danone's Renew strategy, which aims to step up its efforts in science and innovation in response to growing consumer demand for healthy products.
Copyright (c) 2025 CercleFinance.com. All rights reserved.

















